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Abstract
Objectives: To assess: 1) the feasibility of electronic information provision; 2) gather evidence on the topics and
level of detail of information potential research participant’s accessed; 3) to assess satisfaction and understanding.
Design: Observational study with an embedded randomised controlled trial.
Setting: Low risk intervention study based in primary care.
Participants: White British & Irish, South Asian and African-Caribbean subjects aged between 40-74 years eligible
for a blood pressure monitoring study.
Interventions: PDF copy of the standard paper participant information sheet (PDF-PIS) and an electronic Interactive
Information Sheet (IIS) where participants could choose both the type and level of detail accessed.
Main Outcome Measures: 1) Proportion of participants providing an email address and accessing electronic
information 2) Willingness to participate in a recruitment clinic. 3) Type and depth of information accessed on the IIS.
4) Participant satisfaction and understanding.
Results: 1160 participants were eligible for the study. Of these, 276 (24%) provided an active email address, of
whom 84 did not respond to the email. 106 responded to the email but chose not to access any electronic information
and were therefore ineligible for randomisation. 42 were randomised to receive the PDF-PIS and 44 to receive the IIS
(with consent rates of 48% and 36%, respectively; odds ratio 0.6, 95% confidence interval 0.25 to 1.4). Electronic
observation of information accessed by potential participants showed 41% chose to access no information and only
9% accessed the detail presented on the Research Ethics Committee approved participant information sheet before
booking to attend a recruitment clinic for the intervention study. 63 of the 106 participants (59%) who chose not to
access any electronic information also booked an appointment.
Conclusions: Current written information about research may not be read, emphasising the importance of the
consent interview and consideration of new ways of presenting complex information.
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Introduction
Potential participants of medical research need to be
adequately informed about the risks, benefits and processes
involved in order to make an informed decision regarding
participation [1-6]. Normally this information is provided in the
participant information sheet (PIS) and verbally reinforced in
the consent interview [6]. Information provision in research is
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tightly controlled by regulatory codes [6-8] and the content of
the PIS is reviewed by research ethics committees (RECs)[1].
Even with extensive guidance provided by the UK National
Research Ethics Service (NRES) [1], UK researchers often find
it difficult to decide on the level of detail to provide in a PIS[2].
The PIS must be understood by research participants if it is
to aid decision-making[2,9]. Participants are known to struggle
with scientific concepts such as ‘randomisation’, ‘equipoise’,
‘risk’ and ‘probability’. [10-12] The higher the reading level and
the more jargon or technical language used, the less
comprehensible is the PIS, and presentation and length are
key factors in participant understanding [3,13,14].
Information should be provided that meets the needs of
individuals and, when asked using hypothetical scenarios,
people generally say they want more information[15-20]. The
prevailing sense that ‘people want more rather than less
information’ and meeting regulatory requirements may result in
PISs are that are very long: the recommended template alone
runs to 3 pages [1]. This length is now perceived as a deterrent
to participation [1,21,22].
One way forward is to allow participants to choose the level
of information they require to inform their decision, but there is
limited evidence on the feasibility of such an approach or
agreement on whether this would result in them being
sufficiently informed. Antoniou et al. [15] developed an
electronic ‘unfolding’ information sheet for potential participants
of an Internet survey investigating the development of twins
during early childhood. The amount of information participants
accessed was recorded electronically. Only 9-18% of
participants accessed information at the level suggested by a
standard PIS; reported and actual patterns of information
accessed differed significantly[15]. This suggests that asking
potential participants what information they used to make a
participation decision may not yield reliable data.
Building on the work by Antoniou et al [15], the aim of this
study was to assess the feasibility of electronic information
provision and gather evidence on the topics and level of detail
of information potential participant’s accessed when deciding
whether to participate in a piece of low risk interventional
research.
Methods
Ethics
The Birmingham and Black Country Research Ethics
Committee (reference 09/H1202/114) and relevant NHS
authorities reviewed the study as part of the regulatory process
for the parent study. The trial was not registered since it did not
include a health outcome. The full trial protocol can be
accessed by contacting the corresponding author.
Study Design
The information provision (IP) study had three components.
The first addressed the feasibility of electronic information
provision, comparing electronic information provision to a
standard paper PIS. The second was an RCT (IIS RCT) that
compared a PDF version of the same standard PIS (PDF-PIS)
with an interactive electronic information sheet (IIS). The third
was an observational study of participants randomised to the
IIS arm of the IIS RCT and recorded the information accessed
by each participant. Data were collected between 5th February
and 12th December 2011.
The IP study was embedded in a parent study (Blood
Pressure Monitoring in Different Ethnic Groups [BP-Eth]) [23].
Participants of the parent study completed a short survey about
blood pressure monitoring and were then asked to indicate if
they would be interested in taking part in a study comparing
blood pressure measuring methods. The outcome of the IP
study was booking into a recruitment clinic for the parent study.
Everyone expressing an interest in continued participation in
the parent study (whether included in IP study or not) attended
a recruitment clinic, during which the study was explained by a
research nurse and any questions answered prior to formally
consenting (or declining) to participate [23].
Participants
Figure 1 shows how participants were recruited to each
component of the IP study.
The feasibility component included all participants who
wished to continue with the parent study. Demographic data
were collected for the parent study, anonymised and made
available to the IP study. Anyone who provided an email
address was sent an electronic invitation with a link to the
parent study website. If no email address was provided, a
standard paper PIS was posted.
Participants were included in the parallel group RCT and
randomised 1:1 to receive the PDF-PIS or IIS if they clicked the
link to the parent study website, provided their age and gender
(stratification variables) and indicated their willingness to
participate in the IP study.
Interventions
The PDF-PIS was an electronic copy of the parent study
paper PIS that had been approved by an ethics committee (File
S1).
The IIS was based on the unfolding PIS described by
Antoniou et al. [15] and is available to view at http://
mededweb1.bham.ac.uk/KirkbySite/. The IIS presented the
reader with a screen containing a list of frequently asked
questions (FAQ) about the parent study that corresponded to
titles in the paper PIS. Behind each FAQ were up to three
levels of increasingly detailed information. Compared with the
paper PIS, level one contained less detailed information
(minimal information), level two was an exact copy (standard
information), and level three was more detailed (extended
information). Level three also contained links to evidence in
external resources. The level of study information accessed by
each IIS randomised participant was recorded by an SQL
database connected to the website.
Sample size (of the IIS RCT)
Expert opinion of the effect size required to change practice
was used to inform sample calculations [24]. With a predicted
type I error of 5%, a baseline consent rate of 30% and a type II
error of 10%, the calculated total sample size needed to
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determine an effect size (change in rate of participation in the
next phase of the study) of 29%20 was n=132.
Randomisation
The random allocation sequence was generated by HK and
allocated by a central computer linked to the trial website.
Block randomisation was stratified by age and gender. Willing
participants enrolled themselves to the IIS RCT when they
accessed the website. There was no blinding to the assignment
of intervention.
Outcomes
The primary outcomes for each phase of the study were as
follows
1. Feasibility study: proportion of participants that provided an
email address.
2. IIS RCT: booking to attend the recruitment clinic of the
parent study was used as a proxy for being willing to consent.
3. Observational study: amount and type of information
accessed.
Figure 1.  Flow chart of participant recruitment (prepared and submitted as an individual file).  
doi: 10.1371/journal.pone.0076435.g001
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Secondary outcomes included: level of understanding of, and
satisfaction with, the information provided. Participant
understanding of the information provided was assessed using
the validated ‘Quality of Informed Consent tool’ (QuIC) [25]
adapted for use in this study. The satisfaction questionnaire
developed Antoniou et al. [15] was adapted to determine
satisfaction with the information provided.
No changes were made to trial outcomes after trial
commencement. The trial was stopped at ten months. This was
due to funding constraints and because the parent study was
moving to target ethnic minority groups where email addresses
were not being regularly provided.
Statistical methods
All analyses were carried out using SAS version 9.2.
Feasibility study
Each participant was assigned an Index of Multiple
Deprivation (IMD) score [26], based on postcode and
calculated using the GeoConvert tool available through the
official Census website [27]. Low IMD scores indicate high
levels of deprivation.
The proportion of participants providing an email address,
accessing electronic information and levels of understanding
were estimated for each study group (IIS, PDF-PIS, no PIS)
and exploratory analyses were undertaken based on patient
demographics (age, gender, ethnicity, deprivation).
IIS RCT
The IIS RCT analyses were based on the intention to treat
principle. The primary analysis assessed the impact of the IIS
on whether participants booked into recruitment clinics, using
logistic regression accounting for age and gender. Results
were presented as odds ratios with their corresponding 95%
Confidence Limits (95% CL).
Observational study
The potential participants’ use of the IIS was recorded to
produce data about the information accessed by each
individual. The proportion of participants accessing each level
was calculated to show which types and levels of information
were most/least often accessed.
The number of words the average person can read in one
minute was used to determine how long it would take to read
each piece of text on the IIS [28,29]. This calculation was used
to estimate whether the participant had time to read the text or
not. Adjusted analyses were undertaken to exclude data when
the participant could not have read the full text based on the
length of time it was accessed for.
Understanding and satisfaction questionnaire
Everyone who booked an appointment for the recruitment
clinic in the parent study and/or was included in the IIS RCT,
was asked to complete a questionnaire to determine their
understanding of the study and their satisfaction with the way in
which information was provided.
Results
Demographic data are shown in Table 1 and the number of
participants included in each phase on the IP study is shown in
Figure 1.
Feasibility Study
1160 parent study participants were eligible for the IP study.
Of these, 276 (24%) provided an active email address, of
whom 84 did not respond. 106 responded to the invitation
email but did not access any electronic information. This
resulted in an unanticipated study group (the no PIS group). 86
patients were randomised to receive electronic information.
Exploratory analyses suggested that those who provided an
email address were on average younger, more commonly
white and less deprived (Table 1). Also, those participants in
the no PIS group were more deprived than those who
accessed study information. The booking rates showed a trend
towards increased booking in those contacted by email (odds
ratio 1.25, 95% CL 1.0-1.7); the highest booking rate was
observed in the no PIS group (Figure 1). Given the small
sample size, these results should be treated with caution.
IIS RCT
The rate at which participants booked a recruitment interview
was reduced, although not significantly, by using IIS compared
to PDF-PIS (16/44 [36·4%] and 20/42 [47·6%] respectively,
OR=0·6 [95% CL 0·25; 1·4]) (Figure 1). These results should
Table 1. Demographic Data.
 Electronic or paper
Information provision study
groups
 
Email
address
No email
address
(Paper PIS) IIS* PDF-PIS* No PIS
Age      
Mean age (SD) 53·4 (9·3) 58·5 (9·5) 54·5 (9·3) 53·9 (9·8) 54·3 (9·7)
Gender n(%)      
Male 157/290(54%)
430/870
(49%)
24/44
(55%)
25/42
(59%)
52/106
(49%)
Female 133/290(46%)
440/870
(51%)
20/44
(46%)
17/42
(41%)
54/106
(51%)
Ethnicity n (%)      
White 172/290(59%)
470/870
(54%)
31/44
(71%)
31/42
(74%)
57/106
(54%)
Asian 43/290(15%)
175/870
(20%) 2/44 (5%)
4/42
(10%)
19/106
(18%)
Black 59/290(20%)
197/870
(23%)
5/44
(11%)
5/42
(12%)
25/106
(24%)
Deprivation      
Mean IMD
Score (SD) 35·4 (16·9) 38·6 (17·2)
34·6
(17·8)
34·3
(17·8) 38·2 (16·6)
*. denotes a randomised group in the IIS RCT
doi: 10.1371/journal.pone.0076435.t001
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be interpreted with caution as the trial was underpowered to
detect statistically significant differences.
Observational study
41% (18/44) of those randomised to the IIS accessed no
information and were added to the no-PIS group. Only 18%
(8/44) participants accessed any information at the level
provided in the paper PIS (level 2), of these 4 chose to access
at least some additional information in level 3 for one or more
FAQs (Table 2). The median time spent on accessing
information was 57 seconds (IQR 0 to 195 seconds).
Participants were more likely to access information about the
practical aspects of the study, such as the risks and benefits of
taking part (Table 3).
Understanding and satisfaction
An understanding and satisfaction questionnaire was
completed by participants in all groups: paper PIS n=165/271
(60.9%), PDF-PIS n=26/42 (61.9%), IIS n=41/44 (93.2%) and
no PIS n=37/63 (58.7%). The level of understanding was
similar regardless of how much information, if any, was
accessed (Mean score out of 15: No PIS=11 [95% CI 10; 12];
IIS=11 [95% CI 10; 12]; PDF-PIS=11 [95% CI 10; 12]; Paper
PIS=10 [95% CI 10; 11]). Participants across all study groups
were generally satisfied with the level of information they
received, regardless of how much they accessed.
Participants were less likely to want more information about
the parent study if they received study information
electronically; only 1/40 (2.5%) of those in the IIS and 2/24
(8.3%) in the PDF-PIS group wanted more information about
the study compared with 28/137 (20.4%) in the paper PIS
group. One person (1/36; 2.8%) who chose not to access the
PIS before booking a recruitment clinic appointment stated that
s/he would have liked more information about the study. IIS
participants did not accurately recall what information they had
accessed.
Discussion
This study has demonstrated that in an ageing ethnically
diverse group, electronic information provision may prove
challenging as only 25% of potential research participants were
willing to provide an email address and those that did
sometimes provided inaccurate email address or did not
respond.
Two striking sets of results emerged about the way in which
information was used by potential participants at the point of
invitation. First, a large proportion chose not to read any
information about the parent study, and of these, 59% booked
into a recruitment clinic, suggesting that they were willing in
principle to participate in the parent study on the basis of the
information provided in the invitation. Second, observed use of
the IIS suggested that much of the information provided in the
standard, REC reviewed paper information sheet was irrelevant
in determining in principle willingness to participant: 82% of
participants either accessed no information (41%) or only some
of the information provided in level one (41%). Only 8/44 (18%)
participants used information equivalent in level to that of the
paper PIS (but not for every FAQ) and 4 (9%) participants
wanted more information in at least one area. These findings
are consistent with those observed by Antoniou et al. [15],
where 88% of potential participants completed and submitted
the web-based questionnaire without reading the level of
information provided in a standard PIS, and between 28% and
30% chose not to access any information. This study and the
work by Antoniou et al. are, as far as we know, the first to
collect ‘real time’ data on the information read by potential
participants.
Table 2. levels of information accessed in the IIS arm of the
RCT (N=44).
Level of information
Accessing information under
any FAQ n (%)
No levels (had information but chose not to
access any) 18 (41%)
Only needed level one 18 (41%)
Stopped at level two (level of information
identical to UK REC approved paper PIS)  4 (9%)
Needed level three  4 (9%)
Reading Time Median time in seconds (IQR)
Total time spent reading information 57 (0;195)
doi: 10.1371/journal.pone.0076435.t002
Table 3. The proportion of participants who accessed each
FAQ and stayed long enough to have read each level of
information.
 Level one* Level two* Level three*
Purpose of the study 17/44 39% 3/44 7% 1/44 2%
Have to take part 6/44 14% 0/44 0% 0/44 0%
Why been chosen 18/44 41% 4/44 9% 1/44 2%
Expenses 22/44 50% 5/44 11% 1/44 2%
What will happen 13/44 30% 0/44 0% 0/44 0%
Risks 22/44 50% 7/44 16% 2/44 5%
Benefits 20/44 46% 3/44 7% 0/44 0%
Problems 16/44 36% 1/44 2% 0/44 0%
Confidentiality 10/44 23% 1/44 2% 0/44 0%
Don’t want to carry on 6/44 14% 0/44 0% 0/44 0%
GP 14/44 32% 3/44 7% 1/44 2%
Samples 15/44 34% n/a** n/a**
Genetic tests 10/44 23% n/a** n/a**
Results 11/44 25% 1/44 2% 1/44 2%
Organising and funding 10/44 23% 3/44 7% 2/44 5%
Reviewed study 11/44 26% 2/44 5% 2/44 5%
Further info and contact 4/44 9% n/a** n/a**
Accessing any information type 26/44 59% 8/44 18% 4/44 9%
*. Participants who did not access level 1 could not access any of the later levels
and participants who accessed levels 2 and 3 must have accessed the previous
levels to do so and are therefore included in the figures for the previous level.
**. n/a means there was no information available under that level
doi: 10.1371/journal.pone.0076435.t003
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Participant understanding was consistent across groups,
including those who accessed no information. Participants who
did not access information about confidentiality or ethical
review still scored highly on the understanding questionnaire
for these sections, suggesting that their answers were based
on their general knowledge. If this assumption is correct, it may
be sufficient for the standard PIS only to draw attention to
information that is contrary to normal expectations; for
example, when information will not to be kept confidential.
Participants were generally satisfied with the information they
received. This suggests that not only did the majority of people
decide about participation on the basis of very little information,
but they did not want any more information than they read to
make this decision.
Overall, our results suggest that for low risk studies, the
current level of information provided contains more detail than
participants want or are prepared to read. Catering for the
majority, however, and providing less detailed study
information risks providing insufficient information for a
minority. Antoniou et al. [15] suggested allowing participants to
choose what information to access, even if they choose to
access less than is currently regarded as sufficient. They
acknowledged, however, the danger that participants may
thereby not access information that would have impacted on
their decision-making. What constitutes sufficient information
and who should decide this remains debatable. One promising
avenue is the work by Blazeby et al. on core disclosure sets in
routine clinical care, which could draw in a range of
stakeholders (patients, clinicians, sponsors, regulators) in the
context of research [30,31].
There are a number of ways in which information provision
could be modified in other low risk studies. This would be most
straightforward in e-trials where study information is already
provided online and an IIS could be readily incorporated. It is,
however, not always possible or desirable to provide
information in an electronic format, and the outstanding issue
remains that of determining what constitutes a sufficient level of
information in the standard paper PIS. For higher risk studies,
sponsors are likely to insist that all participants are provided
with detailed information provision, whether or not they choose
to read it.
Our study suggested that participants who accessed any
information wanted at least some about the purpose of the
study, risks and benefits; other information was rarely
consulted despite conforming to regulatory codes (Table 3)
[6-8]. The written information provided to potential participants
in all low risk studies could, therefore, be radically streamlined
to reflect these results, irrespective of whether it is provided in
paper or electronic format. The opportunity to access more
information either via a website or by requesting an additional
lengthier paper PIS could be offered to those who want more
information, and trained personnel would still need to be
available to answer questions during consent interviews.
The majority of participants who were contacted
electronically accessed no study information in the PIS before
booking with a recruitment clinic, though it is possible that the
information provided in the invitation letter was sufficient for
them to reach this decision. If potential participants are not
reading the information provided, attention should turn to the
consent interview as the place to ensure that decisions are
sufficiently informed. This may have implications for the
process of ethical review, as it implies that the written
information provided in the PIS is a less significant a safeguard
to informed decision-making than the verbal information
provided in the consent interview. Scrutiny of the intended
verbal information may therefore be a more appropriate activity
for review boards than scrutiny of the PIS. Certainly, consent
received on the basis of sufficient verbal information would
meet the researchers’ ethical obligations to the participant,
particularly where this information was regularly revisited in a
process of on-going consent. Whether it would provide
researchers and sponsors with sufficient legal safeguards is
debatable, as is the outstanding question of just how much
information is sufficient reach an informed and enduring
judgement about participation.
Strengths and weaknesses of the Study
This prospective study provides data on the feasibility of
contacting and informing potential research participants using
electronic media and provides non-hypothetical data on the
information accessed by those randomised to the IIS.
The age and characteristics of the participants may limit the
generalisability of findings to other groups. Younger
participants maybe more likely to utilise electronic information
than the study population [32,33]. Further, the parent study
may be regarded as a ‘low risk’ observational study and the
findings are not, therefore, readily applicable to studies where
the participants are more vulnerable due to their underlying
condition or impaired mental capacity, or where the proposed
interventions are accompanied by risks of major morbidity,
mortality and reduced health-related quality of life.
Observed consistency in participant understanding across
groups may reflect their general knowledge, but could also
indicate that the questionnaire was insufficiently sensitive.
Furthermore understanding and satisfaction were not assessed
in those receiving the paper based PIS or no PIS if they did not
book a consent appointment. These potential participants may
have had less satisfaction or decreased understanding.
Participants in this study were not randomised to electronic
or postal information provision and those with email addresses
may be more likely to participate in research because of
systematic differences to those without an email address.
Suggestions for future research into information
provision
These data suggest that further studies are required to
determine how and what information is used by people who are
invited to participate in clinical research, including that which is
regarded as higher risk. Such studies need to reflect actual
rather than intended or recalled behaviour, and should also
include whether, how and why information provided at the time
of consent is referred to later on if someone agrees to
participate. This latter data would be useful in determining the
extent to which detailed, extensive, written information is
necessary from the perspective of the research participant.
Informing Potential Participants about Research
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Conclusions
A significant proportion of our participants booked into the
recruitment clinic without reading any information provided in
the PIS in either format (PDF/IIS). This suggests that the
recruitment interview remains vital to ensuring that participants
have sufficient information before they are enrolled in studies.
In our study, understanding was not influenced by the
information provided, suggesting that at least some information
regularly included in the standard PIS is unnecessary, unless it
draws attention to a departure from usual practice. The majority
of our participants accessed much less detailed information on
a narrower range of topics than provided in the standard PIS.
One inference is that information provided prior to the consent
interview could be considerably streamlined in low risk studies.
This leaves open the questions of whether the attention of
ethics committees might be more appropriately focussed on
scrutiny of intended verbal information, and what purpose is
served by more detailed written information in such studies.
Supporting Information
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(DOC)
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approved by ethics.
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